The cellular neurobiology of depression

Musselman, D.L., Evans, D.L. & Nemeroff, C.B. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch. Gen. Psychiatry 55, 580–592 (1998).

Schulz, R. et al. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Intern. Med. 160, 1761–1768 (2000).

Michelson, D. et al. Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176–1181 (1996).

Ciechanowski, P.S., Katon, W.J. & Russo, J.E. Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch. Intern. Med. 160, 3278–3285 (2000).

Murray, C.J. & Lopez, A.D. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436–1442 (1997).

Schatzberg, A.F. & Schildkraut, J.J. Recent studies on norepinephrine systems in mood disorders. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 911–920 (Raven, New York, 1995).

Maes, M. & Meltzer, H.Y. The serotonergic hypothesis of depression. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 921–932 (Raven, New York, 1995).

Willner, P. Dopaminergic mechanisms in depression and mania. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 921–932 (Raven, New York, 1995).

Janowsky, D.S. & Overstreet, D.H. The role of acetylcholine mechanisms in mood disorders. in Psychopharmacology: The Fourth Generation of Progress. (eds. Bloom, F.E. & Kupfer, D.J.) 945–956 (Raven, New York, 1995).

Garlow, S.J., Musselman, D.L. & Nemeroff C.B. The Neurochemistry of Mood Disorders clinical studies. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 348–364 (Oxford Press, New York, 1999).

Drevets, W.C. Neuroimaging studies of mood disorders: Implications for a neural model of major depression. Biol. Psychiatry 48, 813–829 (2000).

Graybiel, A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244–254 (1990).

Drevets, W.C., Gadde, K. & Krishnan, R. Neuroimaging studies of depression. in Neurobiology of Mental Illness. (eds. Charney, D.S., Nester, E.J. & Bunney, B.S.) 394–418 (Oxford Press, New York, 1999).

Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477–501 (2000).

Owens, M.J. & Nemeroff, C.B. Corticotropin-releasing factor antagonists in affective disorders. Expert. Opin. Investig. Drugs 8, 1849–1858 (1999).

Charney, D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59, 11–14 (1998).

Manji, H.K. & Lenox, R.H. Signaling: Cellular insights into the pathophysiology of bipolar disorder. Biol. Psych. 48, 518–530 (2000).

Manji, H.K., Moore, G.J., Rajkowska, G. & Chen, G. Neuroplasticity and cellular resilience in mood disorders. Millennium article. Mol. Psychiatry 5, 578–593 (2000).

Bourne, H.R. & Nicoll, R. Molecular machines integrate coincident synaptic signals. Cell 72, 65–75 (1993).

Bhalla, U.S. & Iyengar, R. Emergent properties of networks of biological signaling pathways. Science 283, 381–387 (1999).

LeDoux, J.E. Emotion. in Handbook of Physiology—The Nervous System, Vol. V. (eds. Mills, J., Mountcastle, V.B., Plum, F. & Geiger, S.R.) 373–417 (Williams & Wilkins, Baltimore, 1987).

Rajkowska, G. et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 45, 1085–1098 (1999).

Rajkowska, G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766–777 (2000).

Öngür, D., Drevets, W.C. & Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Nat. Acad. Sci. USA 95, 13290–13295 (1998).

Coyle, J.T. & Schwarcz, R. Mind glue: implications of glial cell biology for psychiatry. Arch. Gen. Psychiatry 57, 90–93 (2000).

Ullian, E.K., Sapperstein, S.K., Christopherson, K.S. & Barres, B.A. Control of synapse number by glia. Science 291, 657–660 (2001).

Drevets, W. Neuroimaging and neuropathological studies of depression: Implications for the cognitive emotional manifestations of mood disorders. Curr. Op. Neurobiol. 11, 240–249 (2001).

Folstein, S.E., Peyser, C.E., Starkstein, S.E. & Folstein, M.F. Subcortical triad of Huntington's Disease; a model for a neuropathology of depression, dementia and dyskinesia. in Psychopathology and the Brain. (ed. Carroll, B.J.) 65–75 (Raven, New York, 1991).

Starkstein, S.E. & Robinson, R.G. Affective disorders and cerebral vascular disease. Brit. J. Psychiatry 154, 170–182 (1989).

Starkstein, S.E. & Robinson, R.G. Mood disorders in neurodegenerative diseases. Semin. Clin. Neuropsychiatry 4, 272–281 (1996).

Kessler, R.C. The effects of stressful life events on depression. Annu. Rev. Psychol. 148, 191–214 (1997).

McEwen, B.S. Stress and hippocampal plasticity. Ann. Rev. Neurosci. 22, 105–122 (1999).

Sapolsky, R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925–935 (2000).

Brown, E.S., Rush, A.J. & McEwen, B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21, 474–484 (1999).

Sonino, N. & Fava, G.A. Psychosomatic aspects of Cushing's disease. Psychother. Psychosom. 67, 140–146 (1998).

Starkman, M.N. et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol. Psychiatry 46, 1595–1602 (1999).

Steffens, D.C., Tupler, L.A. & Krishnan, R. Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. Psychiatry Res. 83, 95–103 (1998).

Black, I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 41, 108–118 (1999).

Riccio, A., Ahn, S., Davenport, C.M., Blendy, J.A. & Ginty, D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358–2361 (1999).

Bonni, A., Brunet, A., West, A.E., Datta, S.R. & Takasu, M.A. Greenberg ME . Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms. Science 286, 1358–1362 (1999).

Finkbeiner, S. CREB couples neurotrophin signals to survival messages. Neuron 25, 11–14 (2000).

Adams, J.M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322–13226 (1998).

Chen, D.F., Schneider, G.E., Martinou, J.C. & Tonegawa, S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385, 434–439 (1997).

Eriksson, P.S. et al. Neurogenesis in the adult human hippocampus. Nature Med. 4, 1313–1317 (1998).

Duman, R.S., Malberg, J., Nakagawa, S. & D'Sa, C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48, 732–739 (2000).

Gould, E., Tanapat, P., Rydel, T. & Hastings, N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiatry 48, 715–720 (2000).

Jacobs, B.L., Praag, H. & Gage, F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry. 5, 262–269 (2000).

Gould, E., Reeves, A.J., Graziano, M.S. & Gross, C.G. Neurogenesis in the neocortex of adult primates. Science 286, 548–552 (1999).

Graham, Y.P., Heim, C., Goodman, S.H., Miller, A.H. & Nemeroff, C.B. The effects of neonatal stress on brain development: Implications for psychopathology. Dev. Psychopathol. 11, 545–565 (1999).

Heim, C. & Nemeroff, C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry 46, 1509–1522 (1999).

Francis, D., Diorio, J., Liu, D. & Meaney, M.J. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286, 1155–1158 (1999).

Duman, R.S., Heninger, G.R. & Nestler, E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54, 597–606 (1997).

Malberg, J.E., Eisch, A.J., Nestler, E.J. & Duman, R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104–9410 (2000).

Manji, H.K. et al. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. in Bipolar Medications: Mechanisms of Action. (eds. Manji, H.K., Bowden, C.L. & Belmaker, R.H.) 129–177 (American Psychiatric Press, Washington, DC, 2000).

Petrie, R.X., Reid, I.C. & Stewart, C.A. The N-methyl-d-aspartate receptor, synaptic plasticity and depressive disorder. A critical review. Pharmacol. Ther. 87, 11–25 (2000).

Chen, G. et al. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72, 879–882 (1999).

Chen, R.W. & Chuang. D.M. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression. J. Biol. Chem. 274, 6039–6042 (1999).

Klein, P.S. & Melton, D,A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455–8459 (1996).

Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N. & Manji, H.K. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75, 1729–1734 (2000).

Tsai, G. & Coyle, J.T. N-acetylaspartate in neuropsychiatric Disorders. Prog. Neuroiology 46, 531–540 (1995).

Bates, T.E. et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7, 1397–1400 (1996).

Moore, G.J. et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol. Psychiatry 48, 1–8 (2000).

Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen, G. & Manji, H.K. Lithium-induced increase in human brain gray matter. Lancet 356, 1241–1242 (2000).

Calabrese, J.R. et al. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am. J. Psychiatry 156, 1019–1023 (1999).

Berman, R.M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351–354 (2000).

Wolkowitz, O.M. & Reus, V.I. Treatment of depression with antiglucocorticoid drugs. Psychosom. Med. 61, 698–711 (1999).

Nestler, E.J. Antidepressant treatments in the 21st century. Biol. Psychiatry 44, 526–533 (1998).

Guo, Z., Zhou, D. & Schultz, P.G. Designing small-molecule switches for protein–protein interactions. Science 288, 2042–2045 (2000).

Mesulam, M.M. Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24, 521–529 (1999).

Sweatt, J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 1–10 (2001).

Sanacora, G. et al. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56, 1043–1047 (1999).

Lambert, G., Johansson, M., Agren, H. & Friberg, P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch. Gen. Psychiatry 57, 787–793 (2000).